The mineral dissolution function of osteoclasts is dispensable for hypertrophic cartilage degradation during long bone development and growth

Developmental Biology

Volumn 393, Issue 1, 2014, Pages 57-70

  Touaitahuata, Heiani ^a,b   Cres, Gaelle ^a,b   de Rossi, Sylvain ^c   Vives, Virginie ^a,b   Blangy, Anne ^a,b  

^a Centre National de la Recherche Scientifique   (France)

^b UNIV MONTPELLIER   (France)

^c Montpellier RIO Imaging   (France)

Author keywords

Bone; Developmental modeling; Dock5; Endochondral ossification; Growth plate; Osteoclasts

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; CATHEPSIN K; GELATINASE B; MATRIX PROTEIN; MINERAL;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; BONE GROWTH; BONE MASS; BONE STRUCTURE; CARTILAGE DEGENERATION; CELL COUNT; CELL MEMBRANE; CONTROLLED STUDY; DISSOLUTION; DOCK5 GENE; ENCHONDRAL OSSIFICATION; FEMALE; GENE; IN VITRO STUDY; INTRACELLULAR SPACE; LONG BONE; MALE; MOUSE; NONHUMAN; OSTEOCLAST ACTIVITY; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; TRABECULAR BONE;

ANIMALIA; MUS;

BONE; DEVELOPMENTAL MODELING; DOCK5; ENDOCHONDRAL OSSIFICATION; GROWTH PLATE; OSTEOCLASTS;

ACID PHOSPHATASE; ANIMALS; BONE REMODELING; CARTILAGE; CATHEPSIN K; CHONDROCYTES; GUANINE NUCLEOTIDE EXCHANGE FACTORS; ISOENZYMES; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OSSIFICATION, HETEROTOPIC; OSTEOCLASTS; OSTEOGENESIS;

EID: 84905755681     PISSN: 00121606     EISSN: 1095564X     Source Type: Journal    
DOI: 10.1016/j.ydbio.2014.06.020     Document Type: Article

References (47)

1. Akiyama H., Chaboissier M.C., Martin J.F., Schedl A., de Crombrugghe B. The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev. 2002, 16:2813-2828.
2. Baron R., Neff L., Louvard D., Courtoy P.J. Cell-mediated extracellular acidification and bone resorption: evidence for a low pH in resorbing lacunae and localization of a 100-kD lysosomal membrane protein at the osteoclast ruffled border. J. Cell Biol. 1985, 101:2210-2222.
3. Boskey A.L., Gelb B.D., Pourmand E., Kudrashov V., Doty S.B., Spevak L., Schaffler M.B. Ablation of cathepsin k activity in the young mouse causes hypermineralization of long bone and growth plates. Calcif. Tissue Int. 2009, 84:229-239.
4. Brazier H., Pawlak G., Vives V., Blangy A. The Rho GTPase Wrch1 regulates osteoclast precursor adhesion and migration. Int. J. Biochem. Cell Biol. 2009, 41:1391-1401.
5. Brazier H., Stephens S., Ory S., Fort P., Morrison N., Blangy A. Expression profile of RhoGTPases and RhoGEFs during RANKL-stimulated osteoclastogenesis: identification of essential genes in osteoclasts. J. Bone Miner. Res. 2006, 21:1387-1398.
6. D'Alonzo R.C., Kowalski A.J., Denhardt D.T., Nickols G.A., Partridge N.C. Regulation of collagenase-3 and osteocalcin gene expression by collagen and osteopontin in differentiating MC3T3-E1 cells. J. Biol. Chem. 2002, 277:24788-24798.
7. Dao D.Y., Jonason J.H., Zhang Y., Hsu W., Chen D., Hilton M.J., O'Keefe R.J. Cartilage-specific beta-catenin signaling regulates chondrocyte maturation, generation of ossification centers, and perichondrial bone formation during skeletal development. J. Bone Miner. Res. 2012, 27:1680-1694.
8. Ding M., Lu Y., Abbassi S., Li F., Li X., Song Y., Geoffroy V., Im H.J., Zheng Q. Targeting Runx2 expression in hypertrophic chondrocytes impairs endochondral ossification during early skeletal development. J. Cell Physiol. 2012, 227:3446-3456.
9. Dougall W.C., Glaccum M., Charrier K., Rohrbach K., Brasel K., De Smedt T., Daro E., Smith J., Tometsko M.E., Maliszewski C.R., Armstrong A., Shen V., Bain S., Cosman D., Anderson D., Morrissey P.J., Peschon J.J., Schuh J. RANK is essential for osteoclast and lymph node development. Genes Dev. 1999, 13:2412-2424.
10. Drissi M.H., Li X., Sheu T.J., Zuscik M.J., Schwarz E.M., Puzas J.E., Rosier R.N., O'Keefe R.J. Runx2/Cbfa1 stimulation by retinoic acid is potentiated by BMP2 signaling through interaction with Smad1 on the collagen X promoter in chondrocytes. J. Cell Biochem. 2003, 90:1287-1298.
11. Duer M.J., Friscic T., Murray R.C., Reid D.G., Wise E.R. The mineral phase of calcified cartilage: its molecular structure and interface with the organic matrix. Biophys J. 2009, 96:3372-3378.
12. Faccio R., Teitelbaum S.L., Fujikawa K., Chappel J., Zallone A., Tybulewicz V.L., Ross F.P., Swat W. Vav3 regulates osteoclast function and bone mass. Nat. Med. 2005, 11:284-290.
13. Gupta H.S., Schratter S., Tesch W., Roschger P., Berzlanovich A., Schoeberl T., Klaushofer K., Fratzl P. Two different correlations between nanoindentation modulus and mineral content in the bone-cartilage interface. J. Struct. Biol. 2005, 149:138-148.
14. Hayman A.R., Jones S.J., Boyde A., Foster D., Colledge W.H., Carlton M.B., Evans M.J., Cox T.M. Mice lacking tartrate-resistant acid phosphatase (Acp 5) have disrupted endochondral ossification and mild osteopetrosis. Development (Camb., Engl.) 1996, 122:3151-3162.
15. Henriksen K., Sorensen M.G., Jensen V.K., Dziegiel M.H., Nosjean O., Karsdal M.A. Ion transporters involved in acidification of the resorption lacuna in osteoclasts. Calcif. Tissue Int. 2008, 83:230-242.
16. Henriksen K., Sorensen M.G., Nielsen R.H., Gram J., Schaller S., Dziegiel M.H., Everts V., Bollerslev J., Karsdal M.A. Degradation of the organic phase of bone by osteoclasts: a secondary role for lysosomal acidification. J. Bone Miner. Res. 2006, 21:58-66.
17. Hollberg K., Marsell R., Norgard M., Larsson T., Jonsson K.B., Andersson G. Osteoclast polarization is not required for degradation of bone matrix in rachitic FGF23 transgenic mice. Bone 2008, 42:1111-1121.
18. Kornak U., Kasper D., Bosl M.R., Kaiser E., Schweizer M., Schulz A., Friedrich W., Delling G., Jentsch T.J. Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man. Cell 2001, 104:205-215.
19. Laurin M., Fradet N., Blangy A., Hall A., Vuori K., Cote J.F. The atypical Rac activator Dock180 (Dock1) regulates myoblast fusion in vivo. Proc. Natl. Acad. Sci. USA 2008, 105:15446-15451.
20. Li C.Y., Jepsen K.J., Majeska R.J., Zhang J., Ni R., Gelb B.D., Schaffler M.B. Mice lacking cathepsin K maintain bone remodeling but develop bone fragility despite high bone mass. J. Bone Miner. Res. 2006, 21:865-875.
21. Li J., Sarosi I., Yan X.Q., Morony S., Capparelli C., Tan H.L., McCabe S., Elliott R., Scully S., Van G., Kaufman S., Juan S.C., Sun Y., Tarpley J., Martin L., Christensen K., McCabe J., Kostenuik P., Hsu H., Fletcher F., Dunstan C.R., Lacey D.L., Boyle W.J. RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc. Natl. Acad. Sci. USA 2000, 97:1566-1571.
22. Lotinun S., Kiviranta R., Matsubara T., Alzate J.A., Neff L., Luth A., Koskivirta I., Kleuser B., Vacher J., Vuorio E., Horne W.C., Baron R. Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation. J. Clin. Invest. 2013, 123:666-681.
23. Luxenburg C., Geblinger D., Klein E., Anderson K., Hanein D., Geiger B., Addadi L. The architecture of the adhesive apparatus of cultured osteoclasts: from podosome formation to sealing zone assembly. PLoS ONE 2007, 2:e179.
24. Mackie E.J., Tatarczuch L., Mirams M. The skeleton: a multi-functional complex organ: the growth plate chondrocyte and endochondral ossification. J. Endocrinol. 2011, 211:109-121.
25. Margolis D.S., Szivek J.A., Lai L.W., Lien Y.H. Phenotypic characteristics of bone in carbonic anhydrase II-deficient mice. Calcif. Tissue Int. 2008, 82:66-76.
26. Mindell J.A. Lysosomal acidification mechanisms. Annu. Rev. Physiol. 2012, 74:69-86.
27. Neutzsky-Wulff A.V., Sims N.A., Supanchart C., Kornak U., Felsenberg D., Poulton I.J., Martin T.J., Karsdal M.A., Henriksen K. Severe developmental bone phenotype in ClC-7 deficient mice. Dev. Biol. 2010, 344:1001-1010.
28. Nishimura R., Wakabayashi M., Hata K., Matsubara T., Honma S., Wakisaka S., Kiyonari H., Shioi G., Yamaguchi A., Tsumaki N., Akiyama H., Yoneda T. Osterix regulates calcification and degradation of chondrogenic matrices through matrix metalloproteinase 13 (MMP13) expression in association with transcription factor Runx2 during endochondral ossification. J. Biol. Chem. 2012, 287:33179-33190.
29. Nordahl J., Andersson G., Reinholt F.P. Chondroclasts and osteoclasts in bones of young rats: comparison of ultrastructural and functional features. Calcif. Tissue Int. 1998, 63:401-408.
30. Orimo H. The mechanism of mineralization and the role of alkaline phosphatase in health and disease. J. Nippon. Med. Sch. 2010, 77:4-12.
31. Ortega N., Behonick D.J., Colnot C., Cooper D.N., Werb Z. Galectin-3 is a downstream regulator of matrix metalloproteinase-9 function during endochondral bone formation. Mol. Biol. Cell 2005, 16:3028-3039.
32. Ortega N., Wang K., Ferrara N., Werb Z., Vu T.H. Complementary interplay between matrix metalloproteinase-9, vascular endothelial growth factor and osteoclast function drives endochondral bone formation. Dis. Models Mech. 2010, 3:224-235.
33. Ota N., Takaishi H., Kosaki N., Takito J., Yoda M., Tohmonda T., Kimura T., Okada Y., Yasuda H., Kawaguchi H., Matsumoto M., Chiba K., Ikegami H., Toyama Y. Accelerated cartilage resorption by chondroclasts during bone fracture healing in osteoprotegerin-deficient mice. Endocrinology 2009, 150:4823-4834.
34. Rousselle A.V., Heymann D. Osteoclastic acidification pathways during bone resorption. Bone 2002, 30:533-540.
35. Ruivo R., Anne C., Sagne C., Gasnier B. Molecular and cellular basis of lysosomal transmembrane protein dysfunction. Biochim. Biophys. Acta 2009, 1793:636-649.
36. Schinke T., Schilling A.F., Baranowsky A., Seitz S., Marshall R.P., Linn T., Blaeker M., Huebner A.K., Schulz A., Simon R., Gebauer M., Priemel M., Kornak U., Perkovic S., Barvencik F., Beil F.T., Del Fattore A., Frattini A., Streichert T., Pueschel K., Villa A., Debatin K.M., Rueger J.M., Teti A., Zustin J., Sauter G., Amling M. Impaired gastric acidification negatively affects calcium homeostasis and bone mass. Nat. Med. 2009, 15:674-681.
37. Seifert M.F., Marks S.C. Morphological evidence of reduced bone resorption in the osteosclerotic (oc) mouse. Am. J. Anat. 1985, 172:141-153.
38. Shen G. The role of type X collagen in facilitating and regulating endochondral ossification of articular cartilage. Orthod. Craniofac. Res. 2005, 8:11-17.
39. Soriano P., Montgomery C., Geske R., Bradley A. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 1991, 64:693-702.
40. Stickens D., Behonick D.J., Ortega N., Heyer B., Hartenstein B., Yu Y., Fosang A.J., Schorpp-Kistner M., Angel P., Werb Z. Altered endochondral bone development in matrix metalloproteinase 13-deficient mice. Development (Camb., Engl.) 2004, 131:5883-5895.
41. Vaananen H.K., Zhao H., Mulari M., Halleen J.M. The cell biology of osteoclast function. J. Cell Sci. 2000, 113(3):377-381.
42. Vives V., Laurin M., Cres G., Larrousse P., Morichaud Z., Noel D., Cote J.F., Blangy A. The Rac1 exchange factor Dock5 is essential for bone resorption by osteoclasts. J. Bone Miner. Res. 2011, 26:1099-1110.
43. Vu T.H., Shipley J.M., Bergers G., Berger J.E., Helms J.A., Hanahan D., Shapiro S.D., Senior R.M., Werb Z. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 1998, 93:411-422.
44. Xiong J., Onal M., Jilka R.L., Weinstein R.S., Manolagas S.C., O'Brien C.A. Matrix-embedded cells control osteoclast formation. Nat. Med. 2011, 17:1235-1241.
45. Yamazaki H., Sasaki T. Effects of osteoprotegerin administration on osteoclast differentiation and trabecular bone structure in osteoprotegerin-deficient mice. J. Electron Microsc. (Tokyo) 2005, 54:467-477.
46. Yang Y., Topol L., Lee H., Wu J. Wnt5a and Wnt5b exhibit distinct activities in coordinating chondrocyte proliferation and differentiation. Development (Camb., Engl.) 2003, 130:1003-1015.
47. Zheng Q., Zhou G., Morello R., Chen Y., Garcia-Rojas X., Lee B. Type X collagen gene regulation by Runx2 contributes directly to its hypertrophic chondrocyte-specific expression in vivo. J. Cell Biol. 2003, 162:833-842.